Category: Publications

Sero-prevalence findings from metropoles in Pakistan: implications for assessing COVID-19 prevalence and case-fatality within a dense, urban working population

Population-level serologic testing has demonstrated groundbreaking results in monitoring the prevalence and case-fatality of COVID-19 within a population.

14. August 2020

Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults

England, UK has experienced a large outbreak of SARS-CoV-2 infection.

14. August 2020

SARS-CoV-2 seroprevalence survey among 18,000 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region

The objective of this study was to perform a large seroprevalence survey on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among Danish healthcare workers to identify high risk groups.

12. August 2020

High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; a prospective cohort study in England

We investigated six London care homes experiencing a COVID-19 outbreak and found very high rates of SARS-CoV-2 infection among residents and staff.

12. August 2020

Covid-19 serology in nephrology health care workers

Chronic kidney disease patients show a high mortality in case of a SARS-CoV-2 infection.

26. July 2020

Seroprevalence of SARS-CoV-2 IgG Antibodies in Utsunomiya City, Greater Tokyo, after first pandemic in 2020 (U-CORONA): a household- and population-based study

The number of confirmed cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Japan are substantially lower in comparison to the US and UK, potentially due to the under-implementation of polymerase chain reaction (PCR) tests.

26. July 2020

SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study

SARS-CoV-2 has driven a pandemic crisis. Serological surveys have been conducted to establish prevalence for covid-19 antibody in various cohorts and communities. However, the prevalence among healthcare workers is still being analyzed.

25. July 2020

SARS-CoV-2 serosurvey in Health Care Workers of the Veneto Region

The ongoing outbreak of coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses formidable challenges to all health care systems.

24. July 2020

High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results

Community-level seroprevalence surveys are needed to determine the proportion of the population with previous SARS-CoV-2 infection, a necessary component of COVID-19 disease surveillance.

21. July 2020

Humoral Response Dynamics Following Infection with SARS-CoV-2

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) specific antibodies have been shown to neutralize the virus in-vitro.

21. July 2020

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Plattform for seroprevalence studies on SARS-COV-2

Privacy Policy
Impress